01/09/2020
In 2014, Fedora Pharmaceuticals Inc. signed the largest licensing deal ever signed in Canadian biotech history, licensing their beta-lactamase inhibitor to Hoffman J La Roche for US$750 million in addition to royalties.
How did they do it?
In his book titled One Day You’ll Understand, Christopher Micetich lets you take a high-dive into his life and experience the stories that led him to become the president and CEO of Fedora Pharmaceuticals.
Born in 1963 and Founder of six companies, Christopher Micetich is considered a “Serial Entrepreneur”. Before he founded Fedora, he was the COO at SynPhar Laboratories Inc., responsible for all aspects of administration including business development, international affairs, and strategic planning. Outside of his career in specialty pharmaceuticals, Christopher is the founder of Windjammer Java Roasters Inc., a specialty coffee roasting company, and Brass Dome Ventures Ltd., a management and business consultancy.
Fedora continues the pursuit of developing new drugs that save lives. Brass Dome Ventures Ltd. was founded in 2016 and employs a multi-disciplinary team of business experts.
You can find his book at https://www.ckmicetich.com/. I highly recommend picking up a copy!
ventures